» Articles » PMID: 36454517

C-Fos-activated CircRPPH1 Contributes to Glioma Stemness

Overview
Specialty Oncology
Date 2022 Dec 1
PMID 36454517
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cancer stem cells or cancer stemness has been confirmed to a major obstacle for glioma progression and it has also been reported that circRNAs play an important part in cancer progression. This study mainly focuses on revealing the role of circRPPH1 and the underlying mechanisms in glioma cell stemness.

Methods: In vitro experiment including RT-qPCR, Western blot, sphere-formation analysis, and ALDH1 activity, and in vivo tumorigenesis experiments were performed to evaluate the effects of circRPPH1 on glioma cell stemness. Luciferase reporter, ChIP, and DNA pull-down analysis were used to reveal the underlying mechanisms.

Results: It was found that circRPPH1 level was upregulated in glioma cell spheres and facilitated the stemness of glioma cells; C-FOS transcriptionally activated circRPPH1 expression via directly binding to circRPPH1 promoter in glioma cells. Moreover, circRPPH1 promoted the stemness of glioma cells dependent on c-FOS-mediated transcriptional activation.

Conclusions: This study indicates that c-Fos-activated circRPPH1 contributes to glioma stemness and provides a potential target for glioma progression based on the c-FOS/circRPPH1 regulatory axis.

Citing Articles

Circular RNAs in cancer stem cells: Insights into their roles and mechanisms (Review).

Yang L, Yi Y, Mei Z, Huang D, Tang S, Hu L Int J Mol Med. 2025; 55(3).

PMID: 39930823 PMC: 11781527. DOI: 10.3892/ijmm.2025.5491.


Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration.

Myers B, Brayer K, Paez-Beltran L, Villicana E, Keith M, Suzuki H Nat Commun. 2024; 15(1):10363.

PMID: 39609428 PMC: 11605073. DOI: 10.1038/s41467-024-54750-9.


ROR1 facilitates glioblastoma growth via stabilizing GRB2 to promote c-Fos expression in glioma stem cells.

Zhu H, Cheng L, Liu D, Ma X, Chen Z, Fan H Neuro Oncol. 2024; 27(3):695-710.

PMID: 39447031 PMC: 11889726. DOI: 10.1093/neuonc/noae224.

References
1.
Zhu H, Liu D, Cheng L, Liu J, Wang G, Li H . Prognostic Value and Biological Function of Galectins in Malignant Glioma. Front Oncol. 2022; 12:834307. PMC: 9263596. DOI: 10.3389/fonc.2022.834307. View

2.
Batlle E, Clevers H . Cancer stem cells revisited. Nat Med. 2017; 23(10):1124-1134. DOI: 10.1038/nm.4409. View

3.
Wang J, Quan Y, Lv J, Gong S, Dong D . BRD4 promotes glioma cell stemness via enhancing miR-142-5p-mediated activation of Wnt/β-catenin signaling. Environ Toxicol. 2019; 35(3):368-376. DOI: 10.1002/tox.22873. View

4.
Tachon G, Masliantsev K, Rivet P, Desette A, Milin S, Gueret E . MEOX2 Transcription Factor Is Involved in Survival and Adhesion of Glioma Stem-like Cells. Cancers (Basel). 2021; 13(23). PMC: 8672280. DOI: 10.3390/cancers13235943. View

5.
Zhang L, Yin Y, Chen H, Feng S, Liu J, Chen L . TRIM24 promotes stemness and invasiveness of glioblastoma cells via activating Sox2 expression. Neuro Oncol. 2020; 22(12):1797-1808. PMC: 7746937. DOI: 10.1093/neuonc/noaa138. View